scispace - formally typeset
Open AccessJournal ArticleDOI

Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics.

TLDR
The immune simulation was conducted and conformed that the vaccine constructs can induces both acquired and humoral immunity effectively against COVID-19 at very low concentration, but along with bioinformatics study the need to conduct experiment in laboratory to validate its safety and effectiveness.
About
This article is published in Heliyon.The article was published on 2020-11-01 and is currently open access. It has received 19 citations till now. The article focuses on the topics: Peptide vaccine & Vaccination.

read more

Citations
More filters
Journal ArticleDOI

Immune Response to SARS-CoV-2 Vaccines

TL;DR: This review has compiled the immune response to SARS-CoV-2 infection and followed by the mechanism of action of various vaccine platforms such as mRNA vaccines, Adenoviral vectored vaccine, inactivated virus vaccines and subunit vaccines in the market.
Journal ArticleDOI

SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways.

TL;DR: In this paper, a review discusses about COVID-19 subunit vaccines adjuvants and their signaling pathways, which could provide a new strategy against the COVID19 pandemic.
Journal ArticleDOI

A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron

TL;DR: In this paper , a multiepitope multivariant vaccine was designed using immunoinformatics and in silico approaches, which is composed of highly promiscuous and strong HLA binding CD4+ and CD8+ T cell epitopes of the S, M, N, E, ORF1ab, ORFs 6 and ORF8 proteins.
Journal ArticleDOI

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models

TL;DR: It is believed that the peptide-based vaccine can be a safe and effective vaccine against COVID-19, particularly because of the flexibility of including new peptides to prevent emerging SARS-CoV-2 variants and avoiding unwanted autoimmune responses.
Posted ContentDOI

Immunoinformatics approach for a novel multi-epitope vaccine construct against spike protein of human coronaviruses

TL;DR: In this article, a broad-spectrum multi-epitope vaccine candidate against S protein of human coronavirus was proposed and evaluated for antigenicity, allergenicity, solubility, and its ability to achieve high-level expression in bacterial hosts.
References
More filters
Journal ArticleDOI

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

TL;DR: AutoDock Vina achieves an approximately two orders of magnitude speed‐up compared with the molecular docking software previously developed in the lab, while also significantly improving the accuracy of the binding mode predictions, judging by tests on the training set used in AutoDock 4 development.
Journal ArticleDOI

A new coronavirus associated with human respiratory disease in China.

TL;DR: Phylogenetic and metagenomic analyses of the complete viral genome of a new coronavirus from the family Coronaviridae reveal that the virus is closely related to a group of SARS-like coronaviruses found in bats in China.
Book ChapterDOI

Protein identification and analysis tools in the ExPASy server

TL;DR: Details are given about protein identification and analysis software that is available through the ExPASy World Wide Web server and the extensive annotation available in the Swiss-Prot database is used.
Journal ArticleDOI

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

TL;DR: It is found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells, indicating that ACE2 is a functional receptor for SARS-CoV.
Related Papers (5)